Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination

Vaccine
Ning SongPeter McIntyre

Abstract

This study evaluates the evidence for elimination of rubella and congenital rubella syndrome (CRS) in Australia, drawing on three national serosurveys conducted between 1996 and 2007 and supported by statutory notification and vaccine coverage data. Anti-rubella IgG seropositivity was defined as ≥ 10 IU/ml by EIA. Between 1998 and 2007, rubella notifications fell >100-fold, to an average of 2 cases per million and there were five confirmed cases of CRS, two of which were locally acquired in 2003. Weighted overall seropositivity remained constant among 1-49 year-olds (89.6% in 1999; 88.1% in 2007). Between 2002 and 2009, 95% of children received at least one dose of the measles-mumps-rubella (MMR) vaccine. All three serosurveys provided estimates for R less than 0.5, well below the epidemic threshold of 1. All available data are supportive of Australia being considered for elimination status. Further reductions in incidence of CRS will require continued attention to vaccine coverage in overseas-born women, as well as the maintenance of current high coverage level of two-dose MMR vaccination.

References

Aug 1, 1990·Archives of Disease in Childhood·E Miller
Apr 1, 1986·The Journal of Hygiene·D J NokesM J Anderson
Mar 1, 1985·Reviews of Infectious Diseases·M A MenserL J Upfold
Feb 24, 2001·Epidemiology and Infection·W J EdmundsN J Gay
Nov 6, 2001·Epidemiology and Infection·G L GilbertM A Burgess
Feb 16, 2007·Vaccine·Heather F GiddingPeter B McIntyre
Apr 19, 2008·The Journal of Infectious Diseases·Irja DavidkinHeikki Peltola
Feb 7, 2009·Bulletin of the World Health Organization·Anita E HeywoodHeath A Kelly
Aug 8, 2009·The Journal of Infectious Diseases·Charles W LeBaronBradley J Sullivan

❮ Previous
Next ❯

Citations

Sep 23, 2014·Iranian Red Crescent Medical Journal·Rahim Barari SawadkohiMohammad Pournasrollah
Feb 13, 2015·Japanese Journal of Infectious Diseases·Weiyan LinJindong Ni
Jan 10, 2013·Human Vaccines & Immunotherapeutics·Irene BarrabeigUNKNOWN Rubella Surveillance Group of Catalonia
Jun 15, 2016·Tropical Medicine & International Health : TM & IH·Felicity T Cutts, Matt Hanson
Sep 10, 2015·The Cochrane Database of Systematic Reviews·Megan K YoungMieke L van Driel
Jul 27, 2018·Human Vaccines & Immunotherapeutics·Seyed Mohsen ZahraeiManoochehr Karami
Nov 27, 2015·Clinical Microbiology Reviews·Wayne DimechChristelle Vauloup-Fellous
Mar 18, 2019·Communicable Diseases Intelligence·UNKNOWN NNDSS Annual Report Working Group
Jun 23, 2020·American Journal of Reproductive Immunology : AJRI·Wan-Ju KungChing-Chiang Lin
Jun 17, 2015·Risk Analysis : an Official Publication of the Society for Risk Analysis·Kimberly M Thompson, Cassie L Odahowski
Aug 25, 2020·Communicable Diseases Intelligence·Cyra PatelPeter McIntyre
Nov 21, 2012·The Medical Journal of Australia·Teresa M Ballestas, Suzanne P McEvoy
Nov 19, 2019·Communicable Diseases Intelligence·Aditi DeyPeter McIntyre
Aug 16, 2019·Communicable Diseases Intelligence·UNKNOWN National Centre for Immunisation Research and Surveillance (NCIRS)Peter McIntyre
Jun 3, 2021·Communicable Diseases Intelligence·UNKNOWN NNDSS Annual Report Working Group
Nov 9, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Anna Glynn-RobinsonDavid N Durrheim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.